Otsuka Holdings Co Ltd 4578
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ¥11,465.00
- Day Range
- ¥11,210.00–11,415.00
- 52-Week Range
- ¥7,756.00–12,795.00
- Bid/Ask
- ¥11,345.00 / ¥11,350.00
- Shares Outstanding
- 524.61M
- Market Cap
- ¥5.96T
- Volume/Avg
- 510,200 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 15.03
- Price/Sales
- 2.32
- Dividend Yield (Trailing)
- 1.48%
- Dividend Yield (Forward)
- 1.74%
- Dividend Payment Schedule
- Mar, Sep
- Total Yield
- 1.96%
Company Profile
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 43,033
- Website
- https://www.otsuka.com
Valuation
|
Metric
|
4578
|
|---|---|
Price/Earnings (Normalized) | 15.03 |
Price/Book Value | 1.86 |
Price/Sales | 2.32 |
Price/Cash Flow | 11.42 |
Price/Earnings
4578
Financial Strength
|
Metric
|
4578
|
|---|---|
Quick Ratio | 1.49 |
Current Ratio | 2.21 |
Interest Coverage | 62.04 |
Quick Ratio
4578
Profitability
|
Metric
|
4578
|
|---|---|
Return on Assets (Normalized) | 10.47% |
Return on Equity (Normalized) | 14.41% |
Return on Invested Capital (Normalized) | 12.92% |
Return on Assets
4578
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| LOCK|<%&Xh<L | LOCK|@? | $1T | |||
| Johnson & Johnson
JNJ
| LOCK|zTDMph% | LOCK|d? | $623B | |||
| AbbVie Inc
ABBV
| LOCK|yVG&pgS | LOCK|<L | $459B | |||
| Merck & Co Inc
MRK
| LOCK|L^lf%Q | LOCK|#< | $355B | |||
| Roche Holding AG ADR
RHHBY
| LOCK|kMm?SFM! | LOCK|yd& | $334B | |||
| Novartis AG ADR
NVS
| LOCK|?X&j$b%? | LOCK|Q! | $268B | |||
| AstraZeneca PLC
AZN
| LOCK|KLr?wmsx | LOCK|??p | $248B | |||
| Amgen Inc
AMGN
| LOCK|s<?Z$^Pz | LOCK|?!# | $220B | |||
| Gilead Sciences Inc
GILD
| LOCK|fH>^&V | LOCK|Pq | $183B | |||
| Novo Nordisk AS ADR
NVO
| LOCK|c<Q>%^ | LOCK|g# | $167B |
United States